Phase 4
Completed N=35
Topical Antimicrobial Effectiveness Testing
Antimicrobial Effectiveness
Source: ClinicalTrials.gov NCT01314703 ↗
Enrolled (actual)
35
Serious AEs
0.0%
Results posted
Aug 2012
Primary outcomePrimary: Antimicrobial Efficacy Will be Measured by the Change (+/-) in Bacterial Count on the Skin 10 Minutes After a Single Application of Test Material Relative to the Baseline Bacterial Count. — 2.8469; 2.5328; 4.038; 3.5295 log 10 colony forming units
Summary
The primary objective of this study is to measure the antimicrobial effectiveness of ChloraPrep one-Step.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Antimicrobial Efficacy Will be Measured by the Change (+/-) in Bacterial Count on the Skin 10 Minutes After a Single Application of Test Material Relative to the Baseline Bacterial Count. |
2.8469; 2.5328; 4.038; 3.5295 | — |
Eligibility Criteria
Inclusion Criteria
- in good general health
- have skin within 6 inches of the test sites that is free of tattoos, dermatoses, abrasions, cuts, lesions or other skin disorders.
Exclusion Criteria
- topical or systemic antimicrobial exposure within 14 days prior to Screening Day
Data sourced from ClinicalTrials.gov (NCT01314703). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.